Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Brain Behav Immun ; 101: 288-303, 2022 03.
Article in English | MEDLINE | ID: mdl-35065196

ABSTRACT

Recent studies have shown that the aryl hydrocarbon receptor (AhR) is expressed in the brain's native immune cells, known as microglia. However, while the impact of exposure to AhR ligands is well studied in the peripheral immune system, the impact of such exposure on immune function in the brain is less well defined. Microglia serve dual roles in providing synaptic and immunological support for neighboring neurons and in mediating responses to environmental stimuli, including exposure to environmental chemicals. Because of their dual roles in regulating physiological and pathological processes, cortical microglia are well positioned to translate toxic stimuli into defects in cortical function via aberrant synaptic and immunological functioning, mediated either through direct microglial AhR activation or in response to AhR activation in neighboring cells. Here, we use gene expression studies, histology, and two-photon in vivo imaging to investigate how developmental exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), a high-affinity and persistent AhR agonist, modulates microglial characteristics and function in the intact brain. Whole cortical RT-qPCR analysis and RNA-sequencing of isolated microglia revealed that gestational and lactational TCDD exposure produced subtle, but durable, changes in microglia transcripts. Histological examination and two-photon in vivo imaging revealed that while microglia density, distribution, morphology, and motility were unaffected by TCDD exposure, exposure resulted in microglia that responded more robustly to focal tissue injury. However, this effect was rectified with depletion and repopulation of microglia. These results suggest that gestational and lactational exposure to AhR ligands can result in long-term priming of microglia to produce heightened responses towards tissue injury which can be restored to normal function through microglial repopulation.


Subject(s)
Polychlorinated Dibenzodioxins , Female , Humans , Lactation , Ligands , Microglia/metabolism , Polychlorinated Dibenzodioxins/metabolism , Polychlorinated Dibenzodioxins/toxicity
2.
Neurosci Lett ; 742: 135516, 2021 01 18.
Article in English | MEDLINE | ID: mdl-33227371

ABSTRACT

Microglia, the immune cells of the brain, have a canonical role in regulating responses to neurological disease or injury, but have also recently been implicated as regulators of neurophysiological processes such as learning and memory. Given these dual immune and physiological roles, microglia are a likely mechanism by which external toxic stimuli are converted into deficits in neuronal circuitry and subsequently function. However, while it is well established that exposure to environmental toxicants negatively affects the peripheral immune system, it remains unknown whether and how such exposure causes neuroinflammation which, in turn, may negatively impact microglial functions in vivo. Here, we examined how acute 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposure in adulthood, which negatively impacts immune cells in the periphery, affects microglial characteristics in the cortex of the mouse. We found that microglia density, distribution, morphology, inflammatory signaling, and response to a secondary, pathological activation were unaffected by acute TCDD exposure. These results suggest that acute, peripheral TCDD exposure in adulthood is not sufficient to induce an overt inflammatory phenotype in cortical microglia.


Subject(s)
Cerebral Cortex/drug effects , Cerebral Cortex/metabolism , Environmental Pollutants/toxicity , Microglia/drug effects , Microglia/metabolism , Polychlorinated Dibenzodioxins/toxicity , Animals , Cerebral Cortex/pathology , Female , Male , Mice , Mice, Inbred C57BL , Microglia/pathology
3.
Nat Commun ; 7: 10905, 2016 Mar 07.
Article in English | MEDLINE | ID: mdl-26948129

ABSTRACT

Microglia are the resident immune cells of the brain. Increasingly, they are recognized as important mediators of normal neurophysiology, particularly during early development. Here we demonstrate that microglia are critical for ocular dominance plasticity. During the visual critical period, closure of one eye elicits changes in the structure and function of connections underlying binocular responses of neurons in the visual cortex. We find that microglia respond to monocular deprivation during the critical period, altering their morphology, motility and phagocytic behaviour as well as interactions with synapses. To explore the underlying mechanism, we focused on the P2Y12 purinergic receptor, which is selectively expressed in non-activated microglia and mediates process motility during early injury responses. We find that disrupting this receptor alters the microglial response to monocular deprivation and abrogates ocular dominance plasticity. These results suggest that microglia actively contribute to experience-dependent plasticity in the adolescent brain.


Subject(s)
Microglia/metabolism , Neuronal Plasticity , Receptors, Purinergic P2Y12/metabolism , Visual Cortex/physiology , Animals , Dominance, Ocular , Mice , Mice, Inbred C57BL , Neurons/metabolism , Receptors, Purinergic P2Y12/genetics , Synapses/genetics , Synapses/metabolism
4.
Retina ; 17(5): 434-6, 1997.
Article in English | MEDLINE | ID: mdl-9355192

ABSTRACT

BACKGROUND: Bilateral diffuse uveal melanocytic proliferation is a poorly understood disorder characterized by the progressive proliferation of uveal melanocytes associated with a systemic nonocular malignancy. Overexpression of p53 protein plays a role in the loss of regulatory control of normal cell proliferation, and p53 is the most commonly identified oncogenic protein in human malignancies. We tested the hypothesis that the aberrant cellular activity in bilateral diffuse uveal melanocytic proliferation involves the overexpression of p53 protein. METHODS: Eight eyes from four patients with bilateral diffuse uveal melanocytic proliferation were tested for p53 protein using an immunoperoxidase technique with an anti-p53 protein monoclonal antibody sensitive for normal and mutant p53 protein. RESULTS: The p53 protein could not be detected in any of the eight eyes. CONCLUSIONS: The proliferation of uveal melanocytes in bilateral diffuse uveal melanocytic proliferation does not depend on the overexpression of p53 protein. The loss of cellular regulatory control in bilateral diffuse uveal melanocytic proliferation is probably mediated through another mechanism.


Subject(s)
Melanocytes/metabolism , Tumor Suppressor Protein p53/metabolism , Uveal Diseases/metabolism , Antibodies, Monoclonal , Cell Division , Humans , Immunoenzyme Techniques , Melanocytes/cytology , Paraneoplastic Syndromes/metabolism , Uveal Diseases/etiology , Uveal Neoplasms/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL